Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) does about 1.50M shares in volume on a normal day but saw 3335312 shares change hands in the recent trading day. The company now has a market cap of 270.94M USD. Its current market price is $36.99, marking an increase of 27.86% compared to the previous close of $28.93. The 52 week high reached by this stock is $594.88 whilst the lowest price level in 52 weeks is $6.76.
The consensus objective for the share price is $70.00, suggesting that the stock has a potential upside of 47.16% over the period.
FactSet Research has provided data showing that 5 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 4 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
ROTH Capital upgraded the stock to “Buy” from Neutral on April 18, 2019 at a price target of $4. ROTH Capital upgraded its price target at $6.
The current price level is 61.35%, 79.89%, and 72.05% away from its SMA20, SMA50, and SMA200 respectively, with the TNXP price moving below the 50-day SMA on current market day. Tonix Pharmaceuticals Holding Corp (TNXP) stock is up 39.06% over the week and 107.58% over the past month. Its price is 12.16% year-to-date and -93.92% over the past year.
To reach the target analysts have set, the stock logically needs to grow 47.16 percent from here.
Outstanding shares total 7.32M with insiders holding 0.05% of the shares and institutional holders owning 7.03% of the company’s common stock. The company has a return on investment of -73.00% and return on equity of -91.44%. The beta has a value of 2.06. Price to book ratio is 1.41 and price to sales ratio is 26.99.
